Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 460 word(s) 460 2020-12-15 07:32:33

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. Myofibrillar Myopathy. Encyclopedia. Available online: https://encyclopedia.pub/entry/4433 (accessed on 18 June 2024).
Xu R. Myofibrillar Myopathy. Encyclopedia. Available at: https://encyclopedia.pub/entry/4433. Accessed June 18, 2024.
Xu, Rita. "Myofibrillar Myopathy" Encyclopedia, https://encyclopedia.pub/entry/4433 (accessed June 18, 2024).
Xu, R. (2020, December 23). Myofibrillar Myopathy. In Encyclopedia. https://encyclopedia.pub/entry/4433
Xu, Rita. "Myofibrillar Myopathy." Encyclopedia. Web. 23 December, 2020.
Myofibrillar Myopathy
Edit

Myofibrillar myopathy is part of a group of disorders called muscular dystrophies that affect muscle function and cause weakness. Myofibrillar myopathy primarily affects skeletal muscles, which are muscles that the body uses for movement. In some cases, the heart (cardiac) muscle is also affected.

genetic conditions

1. Introduction

The signs and symptoms of myofibrillar myopathy vary widely among affected individuals, typically depending on the condition's genetic cause. Most people with this disorder begin to develop muscle weakness (myopathy) in mid-adulthood. However, features of this condition can appear anytime between infancy and late adulthood. Muscle weakness most often begins in the hands and feet (distal muscles), but some people first experience weakness in the muscles near the center of the body (proximal muscles). Other affected individuals develop muscle weakness throughout their body. Facial muscle weakness can cause swallowing and speech difficulties. Muscle weakness worsens over time.

Other signs and symptoms of myofibrillar myopathy can include a weakened heart muscle (cardiomyopathy), muscle pain (myalgia), loss of sensation and weakness in the limbs (peripheral neuropathy), and respiratory failure. Individuals with this condition may have skeletal problems including joint stiffness (contractures) and abnormal side-to-side curvature of the spine (scoliosis). Rarely, people with this condition develop clouding of the lens of the eyes (cataracts).

2. Frequency

The prevalence of myofibrillar myopathy is unknown.

3. Causes

Mutations in several genes can cause myofibrillar myopathy. These genes provide instructions for making proteins that play important roles in muscle fibers. Within muscle fibers, these proteins are involved in the assembly of structures called sarcomeres. Sarcomeres are necessary for muscles to tense (contract). The proteins associated with myofibrillar myopathy are normally active on rod-like structures within the sarcomere called Z-discs. Z-discs link neighboring sarcomeres together to form myofibrils, the basic unit of muscle fibers. The linking of sarcomeres and formation of myofibrils provide strength for muscle fibers during repeated muscle contraction and relaxation.

Gene mutations that cause myofibrillar myopathy disrupt the function of skeletal and cardiac muscle. Various muscle proteins form clumps (aggregates) in the muscle fibers of affected individuals. The aggregates prevent these proteins from functioning normally, which reduces linking between neighboring sarcomeres. As a result, muscle fiber strength is diminished.

At least six genes have been associated with myofibrillar myopathy. Mutations in these six genes account for approximately half of all cases of this condition. Mutations in the DES, MYOT, and LDB3 genes are responsible for the majority of cases of myofibrillar myopathy when the genetic cause is known.

4. Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

5. Other Names for This Condition

  • myofibrillar myopathies

References

  1. Ferrer I, Olivé M. Molecular pathology of myofibrillar myopathies. Expert Rev Mol Med. 2008 Sep 3;10:e25. doi: 10.1017/S1462399408000793. Review.
  2. Schröder R, Schoser B. Myofibrillar myopathies: a clinical and myopathologicalguide. Brain Pathol. 2009 Jul;19(3):483-92. doi:10.1111/j.1750-3639.2009.00289.x. Review.
  3. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: clinical, morphological andgenetic studies in 63 patients. Brain. 2004 Feb;127(Pt 2):439-51.
  4. Selcen D. Myofibrillar myopathies. Curr Opin Neurol. 2010 Oct;23(5):477-81.doi: 10.1097/WCO.0b013e32833d38b0. Review.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 465
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020
1000/1000
Video Production Service